Biotech · Private company · Katy, TX, US
HillMed Inc.
Track this companyFree. Adds HillMed Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Botulinum NeurotoxinPhase 1 · Interstitial CystitisClinicalTrials.gov · fetched Nov 12, 2026
- High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical devicePhase 1 · Interstitial CystitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain ManagementEARLY_PHASE1 · NOT_YET_RECRUITING · started Sep 15, 2025ClinicalTrials.gov NCT05062902 · fetched Nov 12, 2026
NIH awards1
- An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain ManagementFiscal year 2024 · $563.2KNIH RePORTER 4R44HD107822-02 · fetched Nov 12, 2026